Search
U.S. Food and Drug Administration (FDA) Unveils Initiative to Slash Drug Review Period to Two Months
1 day ago /
Read about 0 minute
Author：小编
The FDA has introduced the 'National Priority Voucher Program,' designed to expedite drug review times to between one and two months. Additionally, a limited number of priority review vouchers will be awarded to companies that align with national priorities within the program's inaugural year.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
